What it is
The most malignant astrocytic tumor (WHO grade IV). It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma, IDH-mutant), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma, IDH- wildtype). (Adapted from WHO)
Source: Monarch Initiative, MONDO:0018177, fetched 2026-11-10.
Causes
Gene associations arrive in a later milestone.
Source: MedlinePlus, fetched 2026-11-10.
Approved treatments
8 drugs whose FDA (United States) label names this disease under indications. Approval elsewhere differs.
- Bevacizumab (Avastin)
non-small cell lung cancer, in combination with carboplatin and paclitaxel for first-line treatment. ( 1.2 ) Recurrent glioblastoma in adults. ( 1.3 ) Metastatic renal cell carcinoma in combination with interferon alfa. ( 1.4 ) Persistent, recurrent, or metastatic cervical cancer, in combination with paclitaxel and ci
- Bevacizumab-Adcd (Vegzelma)
non-small cell lung cancer, in combination with carboplatin and paclitaxel for first-line treatment. ( 1.2 ) Recurrent glioblastoma in adults. ( 1.3 ) Metastatic renal cell carcinoma in combination with interferon alfa. ( 1.4 ) Persistent, recurrent, or metastatic cervical cancer, in combination with paclitaxel and ci
- Bevacizumab-Awwb (Mvasi)
non-small cell lung cancer, in combination with carboplatin and paclitaxel for first-line treatment. ( 1.2 ) Recurrent glioblastoma in adults. ( 1.3 ) Metastatic renal cell carcinoma in combination with interferon-alfa. ( 1.4 ) Persistent, recurrent, or metastatic cervical cancer, in combination with paclitaxel and ci
- Bevacizumab-Bvzr (Zirabev)
on-small cell lung cancer, in combination with carboplatin and paclitaxel for first-line treatment. ( 1.2 ) • Recurrent glioblastoma in adults. ( 1.3 ) • Metastatic renal cell carcinoma in combination with interferon alfa. ( 1.4 ) • Persistent, recurrent, or metastatic cervical cancer, in combination with paclitaxel an
- Bevacizumab-Maly (Alymsys)
us non-small cell lung cancer, in combination with carboplatin and paclitaxel for first-line treatment. (1.2) Recurrent glioblastoma in adults. (1.3) Metastatic renal cell carcinoma in combination with interferon alfa. (1.4) Persistent, recurrent, or metastatic cervical cancer, in combination with paclitaxel and cispla
- Bevacizumab-Nwgd (Jobevne)
on-small cell lung cancer, in combination with carboplatin and paclitaxel for first-line treatment. ( 1.2 ) • Recurrent glioblastoma in adults. ( 1.3 ) • Metastatic renal cell carcinoma in combination with interferon alfa. ( 1.4 ) • Persistent, recurrent, or metastatic cervical cancer, in combination with paclitaxel an
- Carmustine
agent or in established combination therapy with other approved chemotherapeutic agents in the following: Brain tumors glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, and metastatic brain tumors (1) Multiple myeloma-in combination with prednisone (1) Relapsed or refractory Hodgkin's lymphoma
- Temozolomide
USAGE TEMOZOLOMIDE Capsules are an alkylating drug indicated for the treatment of adult patients with: Newly diagnosed glioblastoma concomitantly with radiotherapy and then as maintenance treatment. ( 1.1 ) Anaplastic astrocytoma ( 1.2 ) Adjuvant treatment of adults with newly diagnosed anaplastic astrocytoma. ( 1.2 )
Source: openFDA drug labels, fetched 2026-11-10.
Latest research
The newest randomized trials, meta-analyses and systematic reviews with this disease in the title. 729 in total.
- Pharmacological targeting of xCT/system Xc- to modulate temozolomide sensitivity in glioma and glioblastoma preclinical models: a focused systematic review
- 5-Aminolevulinic Acid-mediated Photodynamic Therapy for Glioblastoma: A Systematic Review of Intracavitary and Interstitial Approaches with an Illustrative Case
- Metabolic modulation of glioblastoma by dietary intervention: a systematic review
- Neoadjuvant PD1 plus CTLA-4 immune checkpoint blockade in surgically resectable recurrent glioblastoma: a randomized surgical window-of-opportunity trial
- Survival Impact of Supramarginal Resection According to MGMT Promoter Methylation Status in Glioblastoma: A Systematic Review and Meta-analysis
- Awake Craniotomy for Eloquent Region Glioblastoma Classified by Tumor Location-A Retrospective and Prospective Cohort Study
- Discrepancies in inter-rater agreement on resectability of recurrent glioblastoma: Complementary post-hoc analysis of the prospective, randomized DIRECTOR trial
- Systematic review and multilevel meta-analysis of preclinical survival outcomes of Zika virus-based oncolytic therapy in glioblastoma
- Ultra-hypofractionated versus conventional chemoradiation for newly diagnosed glioblastoma: Survival and toxicity results of a multicenter randomized trial
- Impact of PD-1 inhibitor immunotherapy on survival in patients with newly diagnosed and recurrent glioblastoma: a systematic review of comparative evidence
- Spatial patterns of progression in reported glioblastoma cohorts after upfront chemoradiation and salvage therapy: a systematic review and meta-analysis
- Efficacy and safety of 5-aminolevulinic acid-guided surgery versus white-light resection in newly diagnosed glioblastoma: a systematic review and meta-analysis
- Focused ultrasound-mediated blood-brain barrier opening to enhance temozolomide delivery in glioblastoma: a systematic review of preclinical and early clinical evidence
- Focused ultrasound-induced blood-brain barrier modulation for drug delivery in recurrent glioblastoma: A systematic review
- Dose escalation with intraoperative radiotherapy in newly diagnosed glioblastoma (INTRAGO-II): an open-label, multicentre, randomised, controlled, phase 3 trial
- Clinical outcomes of ferroptosis-inducing agents in glioblastoma: A systematic review of clinical trials
- Predictive value of EGFR amplification and EGFRvIII mutation in EGFR-targeted therapy for recurrent glioblastoma: a systematic review
- Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data
- Antidepressant therapy in the management of glioblastoma multiforme: A systematic review and meta-analysis
- Regorafenib in adult patients with recurrent glioblastoma: a single-arm meta-analysis
Source: Europe PMC, fetched 2026-11-10.
Trials recruiting now
420 studies on ClinicalTrials.gov are recruiting (319) or about to (101). Most advanced first. Phase 3 is the last step before approval; Phase 1 is the first time in people.
Phase 4 1 Phase 3 16 Phase 2/3 5 Phase 2 87 Phase 1/2 60 Phase 1 76 Early phase 1 29 No phase given 92 Observational 54
Loading all 420 trials for filtering…
Phase 4, after approval 1
Phase 3 16
- Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
- Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
- Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
- Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
- Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma
- Anterior Temporal Lobectomy in Temporal Glioblastoma
- A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
- Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
- SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
- PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
- Intraoperative Ultrasound for Brain Tumor Surgery Enhanced by AI
- Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma
- Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients
- AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM
Phase 2/3 5
- Antisecretory Factor Glioblastoma Phase 2
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma
- Tris-CAR-T Cell Therapy Targeting CD44 and CD133 in Newly Diagnosed Glioblastoma
- Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer
Phase 2 87
- Pharmacoscopy for Patients With Refractory Primary Brain Tumors
- VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
- Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma
- Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma
- GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
- Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow
- Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.
- Vortioxetine for Newly Diagnosed Glioblastoma
- Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
- A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
- Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study
- Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
- A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
- Prophylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk Glioblastoma
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
- Intensified Adjuvant Therapy for High-Risk Newly Diagnosed Glioblastoma With Subtotal Resection or Short-Term Progression
- Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
- Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial
- Daily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatoma
- Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
- Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma
- Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial
- G-CSF After Chemo-radiation in Patients With Glioblastoma
- Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread
- Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
- DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
- Study of Olutasidenib and Temozolomide in HGG
- Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression
- OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
- Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
- A Study of BL-B01D1 in Patients With Recurrent Glioblastoma
- Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma
- Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
- Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Lerapolturev (PVSRIPO) in GBM
- WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
- Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
- DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
Showing the 40 most recent of 87. See every one on ClinicalTrials.gov.
Phase 1/2 60
- Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
- Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
- A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)
- Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
- Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma
- A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma
- A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
- Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
- EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
- Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
- 5G-PEARL: Paxalisib in Malignant Brain Tumours
- A Clinical Trial of P134 Cells in Recurrent Glioblastoma
- Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
- Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
- Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
- Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
- DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
- 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
- New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study
- TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
- A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma
- Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
- PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
- Clinical Study of Oncolytic Virus in Glioblastoma
- Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
- Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
- NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma
- A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
- Glutamate Inhibitors in Glioblastoma
- Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
- Study of Pembrolizumab and M032 (NSC 733972)
- Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
- Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
Showing the 40 most recent of 60. See every one on ClinicalTrials.gov.
Phase 1 76
- TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly Glioma
- A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
- BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma
- Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
- A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma.
- A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid Tumors
- Sitagliptin in Recurrent/Progressive Grade 4 Glioma
- Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas
- First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma
- A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
- Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma
- Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
- Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
- A Study of DEG6498 in Participants With Solid Tumors
- A Study of 177Lu-PSMA-617 in People With Gliomas
- A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma
- GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
- Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
- B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma
- Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy
- PH Sensitive MRI Based Resections of Glioblastoma
- Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
- A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.
- Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
- Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy
- Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
- Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
- BC008-1A Injection for Recurrent CNS WHO G4 Glioma
- D2C7-IT + 2141-V11 Combination Post-resection in rGBM
- Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment
- Anti-GD2 ADC M3554 in Advanced Solid Tumors
- Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
- Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
- Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
- Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
- Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
- Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma
- Sonodynamic Therapy in Patients With Recurrent GBM
- ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
Showing the 40 most recent of 76. See every one on ClinicalTrials.gov.
Early phase 1 29
- Window of Opportunity Study of Lixumistat in Patients With Newly Diagnosed Glioblastoma
- Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
- Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma
- Imaging Acetadote Metabolism in Glioblastoma
- [177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma
- BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors
- Senicapoc and Perampanel for Newly Diagnosed Glioblastoma
- A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases
- Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
- Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
- Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
- Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
- Clinical Trial of BMS-986504 in Recurrent GBM Patients
- A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
- Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma
- Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
- PET-imaging of Two Vartumabs in Patients With Solid Tumors
- Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma
- A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
- Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme
- Implantable Microdevice In Primary Brain Tumors
- Oral Gallium Maltolate for Recurrent Glioblastoma
- Biomarker-guided RAdiation-deferring Treatment in Younger GBM Patients - Pilot Study
- Safety and Feasibility of First-line Avutometinib and Defactinib in Patients With Newly Diagnosed High-grade Gliomas
- Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma
- Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer
- Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma
- WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients
No phase given 92
- Tear Fluid for the Detection of Tumor-associated Extracellular Vesicles in Glioblastoma Patients
- REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma
- Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being
- Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening: Advanced Brain Tumor TheRApy Clinical Trial In Patients Scheduled for shOrt Course radiatioN
- Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)
- The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
- Precision Radiotherapy Enabled by Molecular MRI
- Surgery and Laser Interstitial Thermal Therapy for Bilateral Glioblastomas
- Assessment of Early Post-operative Nuclear Imaging in Neurosurgery: a Safety and Feasibility Study in Patients Operated for Glioblastoma
- NK Cell Therapy for Malignant Solid Brain Tumors
- LITT for Ultra-early GBM Recurrence
- Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures
- Pilot IntraOperative Neuronal Electrophysiology in Tumor rElatEd suRgery
- TTFields Plus FET-PET-Guided Stereotactic Radiosurgery Versus TTFields Alone for Recurrent Glioblastoma (Tarrget 2.0)
- OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients
- Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO]
- Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
- A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
- UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-4
- Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
- Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
- FearLess in NeuroOncology
- Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
- The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
- Allogeneic γδT Cells in Glioblastoma
- Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients With Brain Lesions.
- Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial
- Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI
- Preoperative Preradiotherapy TTFields
- Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression
- Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)
- Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma
- Hypofractionated Radiotherapy
- Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
- Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients
- Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients
- Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques
- Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma
- Predictive Value of Soluble CD146 in Glioblastoma Patients
Showing the 40 most recent of 92. See every one on ClinicalTrials.gov.
Observational, no treatment given 54
- Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:
- Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use
- Metabolomics and Transcriptomics of Low- and High-Grade Gliomas
- Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
- Mental Health and Suicidality in Glioblastoma Patients in Germany
- Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors
- The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
- The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab
- A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression
- Diffuse Gliomas in Reunion Island: Establishment of an Epidemiological, Clinical-biological and Socio-anthropological Cohorte
- Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
- Key Longitudinal Associations With Risk and Glioblastoma Outcomes
- MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy
- Targeted Pediatric High-Grade Glioma Therapy
- Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
- Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
- Psychological and Psychiatric prOfile in Glioblastoma and Head and Neck Cancer
- Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma
- TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
- MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)
- Monitoring of Patients With Diffuse Gliomas Using Circulating miRNAs
- Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
- Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis
- Registering Genomics and Imaging of Tumors (ReGIT)
- Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study
- THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)
- The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
- The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
- Response Assessment During MR-guided Radiation Therapy for Glioblastoma
- PET-Guided Resection in High-Grade Gliomas
- The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- Drug Response Testing and Repurposing Using Glioblastoma Organoid
- Ex VIvo DEtermiNed Cancer Therapy
- Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Glutamate Excitotoxicity and Its Role in Glioblastoma Biology
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Loupe-Based Intraoperative Fluorescence Imaging
- Integrative Analysis of Human Glioblastoma Multiforme
Showing the 40 most recent of 54. See every one on ClinicalTrials.gov.
Source: ClinicalTrials.gov, fetched 2026-11-10.
Where to go
Institutions running these trials, by country. The country picker in the trials section narrows this list too.
🇺🇸United States891
New York
- Lenox Hill Brain Tumor Center 7
- NYU Langone Health 6
- Memorial Sloan Kettering Cancer Center 6
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center 3
- Columbia University Medical Center 3
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) 3
- Icahn School of Medicine at Mount Sinai 2
- Lenox Hill Hospital 2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone 2
- Perlmutter Cancer Center, NYU Langone Health 1
- Memorial Sloan Kettering Cancer Center* 1
- Columbia University Irving Medical Center 1
- New York Langone 1
- Columbia University 1
- New York University Langone's Perlmutter Cancer Institute 1
- Icahn School of Medicine at Mount Sinai - Oncology 1
- Memorial Sloan Kettering Cancer Center New York - Main Campus 1
- New York University Langone Medical Center 1
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center 1
- Local Institution - 2102 1
- Memorial Sloan-Kettering Cancer Center (MSKCC) - New York - Memorial Sloan Kettering Cancer Center (CC)- Westc 1
- Columbia University Medical Center - Herbert Irving Pavilion 1
- East River Medical Imaging 1
- Mount Sinai Hospital 1
- Massive Bio SYNERGY-AI site 1
Boston
- Massachusetts General Hospital 10
- Dana Farber Cancer Institute 8
- Dana-Farber Cancer Institute 7
- Brigham and Women's Hospital 3
- Beth Israel Deaconess Medical Center 2
- Massachusetts General Hospital Cancer Center 2
- Susan Chi 1
- Massachusetts General Hospital - Neurology 1
- Dana-Farber Cancer Institute - Oncology Department 1
- Tufts Medical Center 1
- Dana Farber Cancer Institute. 1
- Massachussetts General Hospital 1
- Brigham and Women Hospital 1
Houston
- MD Anderson Cancer Center 6
- Texas Children's Hospital 4
- M D Anderson Cancer Center 4
- The University of Texas MD Anderson Cancer Center 4
- UT MD Anderson Cancer Center 3
- Baylor College of Medicine 2
- Houston Methodist Neurological Institute 2
- Houston Methodist 1
- University of Texas - MD Anderson Cancer Center 1
- University of Texas MD Anderson Cancer Center 1
- UTHealth Houston 1
- The University of Texas M. D. Anderson Cancer Center 1
- Local Institution - 2104 1
- Yvonne Kew MD, PLLC 1
- Excel Diagnostics & Nuclear Oncology Center 1
- The University of Texas, MD Anderson Cancer Center 1
- Baylor St. Luke's Medical Center 1
- Baylor St. Luke's Medical Center | Baylor College of Medicine 1
- Houston Methodist Hospital 1
- Massive Bio SYNERGY-AI site 1
Los Angeles
- UCLA / Jonsson Comprehensive Cancer Center 4
- Cedars-Sinai Medical Center 4
- USC / Norris Comprehensive Cancer Center 2
- Cedars Sinai Medical Center 2
- University of California, Los Angeles 2
- University of Southern California 2
- University of California at Los Angeles 2
- Keck Medicine of USC 1
- Cedars Sinai - Samuel Oschin Comprehensive Cancer Institute 1
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute 1
- University of California Los Angeles 1
- UCLA Health Bowyer Oncology Center 1
- Keck Medicine of USC Koreatown 1
- Los Angeles General Medical Center 1
- Children's Hospital Los Angeles 1
- Ronald Reagan Medical Center 1
- University of California, Los Angeles (Data Collection Only) 1
- University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology 1
- Oncology Institute for Hope and Innovation 1
San Francisco
- University of California, San Francisco 10
- University of California 2
- Sutter Health 1
- University of California San Fransico 1
- UCSF 1
- University of California at San Francisco 1
- UCSF Helen Diller Medical Center at Parnassus Heights - Neurology 1
- University of California San Francisco 1
- Zuckerberg San Francisco General 1
- Kaiser Foundation Research Institute 1
- University of San Francisco 1
- San Francisco VA Medical Center 1
- University of California, San Francisco (UCSF) 1
- California Pacific Medical Center, Sutter health 1
- Massive Bio SYNERGY-AI site 1
- UCSF Weil Institute for Neurosciences 1
Rochester
- Mayo Clinic in Rochester 10
- Mayo Clinic 4
- Mayo Clinic Hospital 2
- Mayo Clinic - Rochester 1
- University of Rochester Medical Center 1
- Mayo Clinic Cancer Center - Rochester 1
- University of Rochester 1
- Mayo Clinic Cancer Center 1
St Louis
- Washington University School of Medicine 9
- Siteman Cancer Center-South County 2
- Siteman Cancer Center at Christian Hospital 2
- Washington University 1
- Washington University School of Medicine - Siteman Cancer Center 1
- Washington University School of Medicine Siteman Cancer Center 1
- Washington University School of Medicine in St. Louis 1
- Siteman Cancer Center at Washington University 1
- Massive Bio SYNERGY-AI site 1
Chicago
- Northwestern University 5
- Ann & Robert H. Lurie Children's Hospital of Chicago 4
- Northwestern Memorial Hospital 2
- University of Chicago Comprehensive Cancer Center 2
- Rush University Medical Center 1
- University of Chicago 1
- Northwestern Medicine 1
- Northwestern University Robert H Lurie Medical Research 1
- Northwestern Univerity 1
- Massive Bio SYNERGY-AI site 1
Miami
- University of Miami 4
- University of Miami Miller School of Medicine-Sylvester Cancer Center 2
- University of Miami Health 1
- Sylvester Comprehensive Cancer Center* 1
- Miami Cancer Institute 1
- Baptist Health Herbert Wertheim Cancer Institute 1
- University of Miami Hospital and Clinics 1
- University of Miami Hospital 1
- Jackson Memorial Hospital 1
- Miami Herbert Wertheim Cancer Institute 1
- UM Sylvester Comprehensive Cancer Center at Kendall 1
- University of Miami (Data collection only) 1
- Miami Cancer Institute at Baptist Health, Inc. 1
- Miami Cancer Institute, Baptist Health South Florida 1
- Massive Bio SYNERGY-AI site 1
Jacksonville
- Mayo Clinic in Florida 8
- Baptist MD Anderson Cancer Center 2
- Mayo Clinic Hospital 2
- Mayo Clinic - Florida 1
- Mayo Clinic Cancer Center 1
- Mayo Clinic Jacksonville 1
- Mayo Jacksonville 1
- Ascension St. Vincent's 1
- Massive Bio SYNERGY-AI site 1
Durham
- Duke University Medical Center 7
- Duke University 5
- Duke University Health System 4
- Duke Cancer Institute 1
Baltimore
- Maryland Proton Treatment Center 2
- Johns Hopkins University 2
- Oncology- Broadway 2
- University of Maryland/Greenebaum Cancer Center 1
- Johns Hopkins Sidney Kimmel Cancer Center - Baltimore 1
- The Johns Hopkins Sidney Kimmel Cancer Center 1
- Johns Hopkins University/Johns Hopkins Hospital 1
- Johns Hopkins Medical Institution 1
- Johns Hopkins Interventional Radiology Center 1
- Johns Hopkins SKCCC 1
- University of Maryland Greenebaum Cancer Center 1
- Massive Bio SYNERGY-AI site 1
Atlanta
- Emory University 3
- Emory University Hospital/Winship Cancer Institute 3
- Winship Cancer Institute of Emory University 2
- Emory Winship Cancer Institute 1
- Piedmont Atlanta Hospital 1
- Piedmont Oncology Research 1
- Emory University Hospital Midtown 1
- Children's Healthcare of Atlanta - Egleston Hospital 1
- Piedmont Healthcare 1
- Massive Bio SYNERGY-AI site 1
Columbus
- Nationwide Children's Hospital 4
- Ohio State University Comprehensive Cancer Center 3
- Ohio State University 2
- The Ohio State University 1
- Ohio State University Cancer Center 1
- The Ohio State University Comprehensive Cancer Center 1
- Ohio State University Hospital 1
- Ohio State University Medical Center 1
- Massive Bio SYNERGY-AI site 1
Cleveland
- Cleveland Clinic 3
- Cleveland Clinic Taussig Cancer Center 2
- University Hospitals Cleveland Medical Center 2
- Case Western Reserve University 1
- University Hospitals Cleveland Medical Center* 1
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute 1
- Cleveland Clinic Foundation 1
- Local Institution - 2112 1
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center 1
- The Cleveland Clinic 1
Philadelphia
- Children's Hospital of Philadelphia 5
- Thomas Jefferson University Hospital 1
- University of Pennsylvania - Perelman Center for Advanced Medicine 1
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center 1
- Children's Hospital of Philadelphia-Center for Childhood Cancer Research 1
- Hospital of the University of Pennsylvania 1
- University of Pennsylvania 1
- Abramson Cancer Center 1
- Penn Medicine, University of Pennsylvania 1
- Massive Bio SYNERGY-AI site 1
Birmingham
- University of Alabama at Birmingham 5
- University of Alabama at Birmingham Cancer Center 2
- University of Alabama 1
- University of Alabama at Birmingham O'Neal Comprehensive Cancer Center 1
- Childrens of Alabama 1
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital 1
- University of Alabama Birmingham 1
- Massive Bio SYNERGY-AI site 1
Duarte
- City of Hope Medical Center 6
- City of Hope 2
- City of Hope Comprehensive Cancer Center 2
- City of Hope - Duarte Cancer Center 1
- Beckman Research Institute of City of Hope 1
- Massive Bio SYNERGY-AI site 1
Aurora
- Children's Hospital Colorado 4
- University of Colorado Health Cancer Care 1
- University of Colorado Denver 1
- UCHealth Cancer Center - Anschutz Medical Campus - University of Colorado Cancer Center 1
- UCHealth University of Colorado Hospital 1
- Children's Hospital Colorado - Anschutz Medical Campus 1
- University of Colorado Anschutz 1
- University of Colorado Anschutz Medical Campus 1
- Massive Bio SYNERGY-AI site 1
Salt Lake City
- Huntsman Cancer Institute 3
- University of Utah, Huntsman Cancer Institute 2
- Huntsman Cancer Institute/University of Utah 2
- Huntsman Cancer Insititute, University of Utah 1
- University of Utah - Huntsman Cancer Institute 1
- Huntsman Cancer Institute, University of Utah 1
- George E. Wahlen Department of Veterans Affairs Medical Center 1
- Massive Bio SYNERGY-AI site 1
Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center 4
- University of Wisconsin Carbone Cancer Center - University Hospital 4
- University of Wisconsin Health 1
- University of Wisconsin Carbone Cancer Center 1
- University of Wisconsin 1
Pittsburgh
- UPMC Hillman Cancer Center 4
- Allegheny Health Network 2
- Allegheny General Hospital 1
- University of Pittsburgh Medical Center - Hillman Cancer Center 1
- UPMC Presbyterian Hospital 1
- University of Pittsburgh Medical Center 1
- University of Pittsburg Medical Center (UPCM) 1
Phoenix
- St. Joseph's Hospital and Medical Center 5
- Mayo Clinic Hospital 2
- Mayo Clinic - Arizona 1
- Mayo Clinic Hospital in Arizona 1
- Mayo Clinic in Arizona 1
- HonorHeath Scottsdale Osborn Medical Center 1
Seattle
- Seattle Children's Hospital 4
- Fred Hutch Cancer Center 1
- University of Washington Medical Center 1
- University of Washington Fred Hutchinson Cancer Center 1
- Fred Hutchinson Cancer Research Center 1
- Swedish Medical Center 1
- Virginia Mason 1
- Massive Bio SYNERGY-AI site 1
Dallas
- University of Texas Southwestern Medical Center 4
- Baylor, Scott and White Research Institute 1
- Mary Crowley Cancer Research 1
- Baylor Scott & White Research Institute 1
- The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center 1
- UT Southwestern Simmons Cancer Center 1
- Massive Bio SYNERGY-AI site 1
Washington D.C.
- Children's National Medical Center 4
- Sibley Memorial Hospital 2
- Children's National Hospital 2
- Johns Hopkins Sibley Memorial Hospital 1
- MedStar Georgetown University Hospital 1
Winston-Salem
- Wake Forest University Health Sciences 4
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center 1
- Comprehensive Cancer Center of Wake Forest* 1
- Atrium Health Wake Forest Baptist 1
- Wake Forest University 1
- Massive Bio SYNERGY-AI site 1
Nashville
- Vanderbilt-Ingram Cancer Center 2
- Vanderbilt University Medical Center 2
- SCRI Oncology Partners 1
- Tennessee Oncology 1
- Vanderbilt University/Ingram Cancer Center 1
- Sarah Cannon, SCRI Oncology Partners 1
- Massive Bio SYNERGY-AI site 1
Tampa
- Moffitt Cancer Center 5
- Moffitt 1
- H Lee Moffitt Cancer Center & Research Institute 1
- Florida Health Sciences Center, Inc. d/b/a Tampa General Hospital 1
- Massive Bio SYNERGY-AI site 1
Cincinnati
- Cincinnati Children's Hospital Medical Center 4
- University of Cincinnati Cancer Center-UC Medical Center 1
- University of Cincinnati 1
- University of Cincinnati Medical Center 1
- Mayfield Brain and Spine 1
- Massive Bio SYNERGY-AI site 1
Kansas City
- University of Kansas Cancer Center 2
- University of Kansas Cancer Center - Briarcliff 1
- University of Kansas Cancer Center - North 1
- University of Kansas Medical Center 1
- Saint Luke's Cancer Institute 1
- KUMC Dept of Neurosurgery 1
- Massive Bio SYNERGY-AI site 1
San Antonio
- University of Texas Health Mays Cancer Center 1
- The University of Texas Health Science Center at San Antonio 1
- Mays Cancer Center, UT Health San Antonio 1
- University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center 1
- START | San Antonio 1
- South Texas Accelerated Research Therapeutics (START) 1
- The Cancer Therapy and Research Center at UTHSCSA 1
- University of Texas Health Science Center of San Antonio 1
Orange
- UC Irvine Health/Chao Family Comprehensive Cancer Center 3
- St. Joseph Hospital 1
- UC Irvine Health 1
- Chao Family Comprehensive Cancer Center, University of California, Irvine 1
- Massive Bio SYNERGY-AI site 1
Milwaukee
- Medical College of Wisconsin 3
- Froedtert Hospital/Medical College of Wisconsin 1
- Froedtert Hospital - Clinical Cancer Center 1
- Froedtert & the Medical College of Wisconsin 1
- Massive Bio SYNERGY-AI site 1
Orlando
- Advent Health 1
- Orlando Health Cancer Institute 1
- Sarah Cannon Research Institute at Florida Cancer Specialists- Lake Nona 1
- Local Institution - 2105 1
- Local Institution - 2120 1
- Advent Health Orlando 1
- Orlando Health 1
Providence
- Brown University Health 2
- Legorreta Cancer Center Warren Alpert Medical School of Brown University 1
- Rhode Island Hospital 1
- Lifespan / Rhode Island Hospital 1
- Brown University Health/Rhode Island Hospital 1
- Massive Bio SYNERGY-AI site 1
Fairfax
- Inova Schar Cancer Institute 3
- Inova Schar Cancer 1
- NEXT Virginia 1
- NEXT Oncology- Virginia 1
- INOVA Health 1
La Jolla
- UCSD Moores Cancer Center 2
- UC San Diego Moores Cancer Center 2
- University of California San Diego 1
- University of California, San Diego 1
- Massive Bio SYNERGY-AI site 1
Detroit
- Henry Ford Health System 3
- Henry Ford Hospital 2
- Henry Ford Cancer- Detroit 1
- Karmanos Cancer Institute 1
Charlottesville
- University of Virginia 2
- UVA Health, Emily Couric Clinical Cancer Cente 1
- University of Virginia Health 1
- University of Virginia Health System 1
- University of Virginia Cancer Center 1
- Massive Bio SYNERGY-AI site 1
Ann Arbor
- University of Michigan 3
- C.S. Mott Children's Hospital 2
- University of Michigan Rogel Cancer Center 1
- Massive Bio SYNERGY-AI site 1
Omaha
- University of Nebraska Medical Center 3
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy) 1
- XCancer Omaha / Urology Cancer Center 1
- University of Nebraska 1
- Massive Bio SYNERGY-AI site 1
Scottsdale
- Mayo Clinic in Arizona 2
- HonorHealth Scottsdale Osborn Medical Center 1
- Mayo Clinic Scottsdale 1
- Honor Health 1
- Massive Bio SYNERGY-AI site 1
New Brunswick
- Rutgers Cancer Institute 3
- Rutgers Cancer Institute of New Jersey 1
- Local Institution - 2110 1
- Massive Bio SYNERGY-AI site 1
Minneapolis
- Allina Health Systems/Abbott Northwestern Hospital 1
- Atrium Health Levine Cancer Institute 1
- Elizabeth C. Neil, MD 1
- University of Minnesota Radiation Oncology 1
- Abbott Northwestern Hospital 1
- University of Minnesota 1
Irvine
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care 3
- University of California, Irvine 1
- Massive Bio SYNERGY-AI site 1
The Bronx
- Montefiore Medical Center-Einstein Campus 1
- Montefiore Medical Center-Weiler Hospital 1
- Montefiore Medical Center - Moses Campus 1
- Montefiore Medical Center 1
- Montefiore Einstein 1
Palo Alto
- Stanford University 3
- Stanford Cancer Institute 1
- VA Palo Alto 1
Lexington
- University of Kentucky 2
- University of Kentucky/Markey Cancer Center 2
- UK Markey Cancer Center 1
Richmond
- VCU Massey Comprehensive Cancer Center 3
- Children's Hospital of Richmond at VCU 1
- Virginia Commonwealth University 1
Chapel Hill
- UNC Lineberger Comprehensive Cancer Center 1
- University of North Carolina 1
- Lineberger Comprehensive Cancer Center 1
- University of North Carolina Health 1
- Massive Bio SYNERGY-AI site 1
Bethesda
- National Institutes of Health Clinical Center 4
- Massive Bio SYNERGY-AI site 1
Sacramento
- University of California Davis Comprehensive Cancer Center 4
Des Moines
- Iowa Methodist Medical Center 1
- UI Health Care Mission Cancer and Blood - Des Moines Clinic 1
- Broadlawns Medical Center 1
- UI Health Care Mission Cancer and Blood - Laurel Clinic 1
Glen Burnie
- UM Baltimore Washington Medical Center/Tate Cancer Center 1
- Advanced Molecular Imaging and Therapy 1
- United Theranostics - Chesapeake 1
- Baltimore Washington Medical Center 1
Greenville
- East Carolina University 1
- Prisma Health 1
- Vidant Heath - ECU Medical Center 1
- Massive Bio SYNERGY-AI site 1
New Haven
- Yale University 2
- Yale Cancer Center / Smilow Cancer Hospital* 1
- Yale Cancer Center 1
Gainesville
- University of Florida Health 1
- UF Health Shands Hospital 1
- UF Health 1
- University of Florida Health Children's Hospital 1
Indianapolis
- Indiana University 1
- Indiana University (Data Collection Only) 1
- Indiana University School of Medicine 1
- Indiana University, IU Health Methodist Hospital 1
Stanford
- Stanford Cancer Center 1
- Stanford University Medical Center - Neurology 1
- Standford University 1
- Massive Bio SYNERGY-AI site 1
Buffalo
- Dent Neurologic Institute 2
- Roswell Park Cancer Institute 1
- Massive Bio SYNERGY-AI site 1
Hershey
- Penn State Milton S. Hershey Medical Center 2
- Local Institution - 2114 1
- Penn State Health 1
Denver
- Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's 1
- Sarah Cannon, SCRI Oncology Partners - Health One 1
- Centura 1
- Massive Bio SYNERGY-AI site 1
Columbia
- MU Health - University Hospital/Ellis Fischel Cancer Center 1
- University of Missouri 1
- Central Maryland Radiation Oncology 1
Oklahoma City
- University of Oklahoma Health Sciences Center 3
Louisville
- Norton Cancer Institute - Brownsboro 1
- Univeristy of Louisville Health 1
- Norton Cancer Institute 1
Portland
- Oregon Health Science University 1
- OHSU Knight Cancer Institute 1
- Massive Bio SYNERGY-AI site 1
Scarborough
- Maine Health Cancer Care and Blood Disorders - Scarborough 1
- Maine Medical Center 1
- Massive Bio SYNERGY-AI site 1
Charlotte
- Carolinas Medical Center/Levine Cancer Institute 2
- Levine Children's Hospital- Pediatric Neuro-Oncology 1
Iowa City
- University of Iowa Health Care 2
- Massive Bio SYNERGY-AI site 1
O'Fallon
- Cancer Care Center of O'Fallon 1
- HSHS Saint Elizabeth's Hospital 1
Shiloh
- Memorial Hospital East 2
Warrenville
- Northwestern Medicine Cancer Center Warrenville 1
- Northwestern Medicine: Warrenville 1
Westwood
- University of Kansas Hospital-Westwood Cancer Center 2
Bel Air
- UM Upper Chesapeake Medical Center 1
- UCH Kaufman Cancer Center 1
City of Saint Peters
- Siteman Cancer Center at Saint Peters Hospital 2
Creve Coeur
- Siteman Cancer Center at West County Hospital 2
Menomonee Falls
- Froedtert Menomonee Falls Hospital 2
Oak Creek
- Drexel Town Square Health Center 2
West Bend
- Froedtert West Bend Hospital/Kraemer Cancer Center 2
Littleton
- Advent Health - Colorado 1
- Massive Bio SYNERGY-AI site 1
Lebanon
- Dartmouth Hitchcock Medical Center 1
- Dartmouth-Hitchcock Medical Center 1
Valhalla
- Westchester Medical Center 2
Charleston
- Medical University of South Carolina 1
- Medical University of South Carolina - Hollings Cancer Center 1
Newport Beach
- Hoag Memorial Hospital Presbyterian 1
- HOAG 1
Billings
- Billings Clinic 1
- Massive Bio SYNERGY-AI site 1
New Orleans
- LSU Health Sciences Center - New Orleans 1
- Massive Bio SYNERGY-AI site 1
Austin
- Texas Oncology - Austin 1
- Texas Oncology Austin 1
Camden
- Cooper University HealthCare 1
- Cooper University Health Care 1
Summit
- Atlantic Health 2
Lake Success
- Northwell Health Center for Advanced Medicine - Brain Tumor Center 1
- Northwell Health 1
Albany
- Albany Medical Center 2
Gilbert
- Banner MD Anderson Cancer Center 2
Morgantown
- West Virginia University Healthcare 1
- Massive Bio SYNERGY-AI site 1
Burlington
- University of Vermont Medical Center 2
Grand Rapids
- START | Midwest 1
- BAMF Health 1
San Diego
- University of California, San Diego 1
- University of California San Diego 1
Coral Gables
- UM Sylvester Comprehensive Cancer Center at Coral Gables 2
Deerfield Beach
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach 2
Newark
- Rutgers New Jersey Medical School 1
- Massive Bio SYNERGY-AI site 1
Memphis
- St. Jude Children's Research Hospital 1
- Massive Bio SYNERGY-AI site 1
Basking Ridge
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) 2
Middletown
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) 2
Montvale
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) 2
Commack
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) 2
Harrison
- Memorial Sloan Kettering Westchester (Limited Protocol Activities) 1
- Memorial Sloan Kettering Westchester (All Protocol Activities) 1
Mobile
- University of South Alabama 1
- Massive Bio SYNERGY-AI site 1
Little Rock
- University of Arkansas Medical Center 1
- Massive Bio SYNERGY-AI site 1
Englewood
- Colorado Brain & Spine Institute: Swedish Campus 1
- Clinical Research dep. Davison Place. Englewood Health 1
Boise
- St. Alphonsus Regional Medical Center 1
- Massive Bio SYNERGY-AI site 1
Grand Junction
- Saint Mary's Hospital and Regional Medical Center 1
Alton
- Alton Memorial Hospital 1
Decatur
- Decatur Memorial Hospital 1
DeKalb
- Northwestern Medicine Cancer Center Kishwaukee 1
Geneva
- Northwestern Medicine Cancer Center Delnor 1
Ankeny
- UI Health Care Mission Cancer and Blood - Ankeny Clinic 1
Carroll
- Saint Anthony Regional Hospital 1
Clive
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic 1
Pella
- UI Healthcare Mission Cancer and Blood - Pella 1
Waukee
- UI Health Care Mission Cancer and Blood - Waukee Clinic 1
Overland Park
- University of Kansas Cancer Center-Overland Park 1
Lee's Summit
- University of Kansas Cancer Center - Lee's Summit 1
Reno
- Renown Regional Medical Center 1
Appleton
- ThedaCare Regional Cancer Center 1
Johnson Creek
- University of Wisconsin Carbone Cancer Center - Johnson Creek 1
New Berlin
- Froedtert and MCW Moorland Reserve Health Center 1
Neptune City
- Jersey Shore University Medical Center | Hackensack 1
Jackson
- University of Mississippi Medical Center 1
Springdale
- Highlands Oncology Group 1
Hackensack
- John Theurer Cancer Center at Hackensack University Medical Center 1
Long Island City
- Northwell Health 1
Milford
- Dana-Farber Brigham Cancer Center, Milford Hospital 1
South Weymouth
- Dana-Farber Brigham Cancer Center, South Shore Hospital 1
Huntington
- Edwards Comprehensive Cancer Center 1
Grand Forks
- Altru Cancer Center 1
Santa Monica
- Pacific Neuroscience Institute / Saint John's Cancer Institute 1
Tucson
- Arizona Cancer Center at UMC North/University Medical Center 1
Irving
- NEXT Dallas - Oncology Department 1
Beverly Hills
- Precision NextGen Oncology 1
Glendale
- OPN Healthcare, Inc 1
Boynton Beach
- MDR Core Network 1
Tacoma
- Northwest Medical Specialties 1
Orland Park
- University of Chicago Medicine-Orland Park 1
Livingston
- Cooperman Barnabas Medical Center 1
West Chester
- University of Cincinnati Cancer Center-West Chester 1
Uniondale
- Memorial Sloan Kettering Nassau (Limited Protocol Activities) 1
Trumbull
- Smilow Cancer Hospital Care Center-Trumbull 1
Coral Springs
- UM Sylvester Comprehensive Cancer Center at Coral Springs 1
Doral
- UM Sylvester Comprehensive Cancer Center at Doral 1
Hollywood
- UM Sylvester Comprehensive Cancer Center at Hollywood 1
North Miami
- University of Miami Sylvester Comprehensive Cancer Center at Sole Mia 1
Plantation
- UM Sylvester Comprehensive Cancer Center at Plantation 1
Fairway
- University of Kansas Clinical Research Center 1
Mineola
- NYU Langone Hospital - Long Island 1
Rockville Centre
- Memorial Sloan Kettering Nassau (Limited Protocol Activities) 1
Augusta
- Augusta University, Georgia Cancer Center 1
West Los Angeles
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA 1
Chandler
- Chandler Regional Medical Center 1
Stony Brook
- Stony Brook University Hospital 1
Boulder
- University of Colorado Boulder 1
Fresno
- VA Medical Center, Fresno 1
Fruitdale
- Santa Clara Valley Medical Center 1
Fullerton
- St Jude Heritage Medical Group 1
Mather
- Sacramento VA Medical Center - VA Northern California Health Care System 1
Monterey
- Pacific Cancer Care 1
Honolulu
- Spark M. Matsunaga VA Medical Center 1
Las Vegas
- North Las Vegas VA Medical Center 1
Castro Valley
- Eden Medical Center 1
Laguna Hills
- MemorialCare Health System 1
Palm Springs
- Desert Regional Medical Center 1
Clearwater
- BayCare Health 1
Weston
- Cleveland Clinic Florida- Weston 1
Carmel
- Goodman Campbell Brain and Spine 1
Shreveport
- Willis-Knighton Medical Center 1
Syracuse
- SUNY Upstate Medical Center 1
Wilmington
- Atlantic Brain & Spine 1
Kettering
- Kettering Health 1
Allentown
- St Luke's University Health, Sacred Heart Campus 1
Chattanooga
- CHI Memorial Hospital, CommonSpirit 1
The Woodlands
- Texas Oncology-The Woodlands 1
Hartford
- Massive Bio SYNERGY-AI site 1
Norwalk
- Massive Bio SYNERGY-AI site 1
Savannah
- Massive Bio SYNERGY-AI site 1
Silver Spring
- Massive Bio SYNERGY-AI site 1
Towson
- Massive Bio SYNERGY-AI site 1
Worcester
- Massive Bio SYNERGY-AI site 1
Lansing
- Massive Bio SYNERGY-AI site 1
Duluth
- Massive Bio SYNERGY-AI site 1
Hattiesburg
- Massive Bio SYNERGY-AI site 1
Albuquerque
- Massive Bio SYNERGY-AI site 1
Hempstead
- Massive Bio SYNERGY-AI site 1
Manhasset
- Massive Bio SYNERGY-AI site 1
Staten Island
- Massive Bio SYNERGY-AI site 1
Fargo
- Massive Bio SYNERGY-AI site 1
Mayfield Heights
- Massive Bio SYNERGY-AI site 1
Tulsa
- Massive Bio SYNERGY-AI site 1
Temple
- Massive Bio SYNERGY-AI site 1
🇫🇷France124
Lyon
- CHU de Lyon - CHU Lyon - Hopital neurologique Pierre Wertheimer 1
- Centre Leon Berard 1
- Hospices Civils de Lyon - CHU de Lyon, Department of Neuro-Oncology 1
- Local Institution - 6111 1
- Institut d Hematologie et d Oncologie Pediatriques 1
- Centre Leon Berard - Service d'Oncologie Medicale 1
- Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE de l'hôpital de la Croix-Rousse 1
- Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE de l'Hôpital E. Herriot 1
- Service d'Oto-Rhino-Laryngologie de l'Hôpital de la Croix-Rousse 1
- Service d'Urologie de l'Hôpital E. Herriot 1
- Service de Gynécologie de l'hôpital de la Croix-Rousse 1
- Service de Gynécologie du Groupement Hospitalier Est 1
- Service de Pneumologie de l'hôpital de la Croix-Rousse 1
- Service de Pneumologie du Groupement Hospitalier Est 1
- Hôpital Lyon Sud/ service de Radiothérapie Oncologie 1
Paris
- Assistance Publique Hopitaux Paris- APHP - APHP Sorbonne Univ - Hopital la Pitie-Salpetriere (233) 1
- Assistance Publique Hopitaux Paris- APHP - APHP Nord - Univ De Paris Cite - Hop. Saint Louis 1
- Hopital Piti-Salpetriere 1
- Saint Louis Hospital 1
- Pitié Salpêtrière Hospital 1
- Hopital Bichat - Claude Bernard - AP-HP 1
- Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Neurosurgery 1
- Hôpital Saint-Louis - APHP 1
- Department of Neurology, Hopital de la Salpêtrière 1
- Department of Neurology, Hopital Saint louis (APHP) 1
- Local Institution - 6109 1
- Neuro-oncology department, Pitié Salpêtrière hospital 1
- Hopital Saint Louis 1
- Gh Pitie Salpetriere Aphp 1
Marseille
- Hopital de la Timone 1
- Timone Hospital 1
- Centre d'Essais Precoces en Cancerologie de Marseille 1
- Assistance Publique - Hôpitaux de Marseille, Department of Neuro-Oncology 1
- CHU La Timone 1
- Neuro-oncology Department, La Timone Hospital 1
- Hôpitaux Universitaires de Marseille Timone 1
- Local Institution - 6110 1
- Service de Neuro-oncologie 1
- Assistance Publique Hôpitaux de Marseille 1
- Hôpital de La Timone 1
- Centre Hospitalier La Timone 1
Pierre-Bénite
- Service d'Hématologie de l'Hôpital Lyon Sud 1
- Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE du Centre Hospitalier Lyon Sud 1
- Service d'Oncologie médicale du Centre hospitalier Lyon Sud 1
- Service d'Urologie de l'hôpital Lyon Sud 1
- Service de Chirurgie de l'hôpital Lyon Sud 1
- Service de Dermatologie de l'hôpital Lyon Sud 1
- Service de Gynécologie de l'hôpital Lyon Sud 1
- Service de Pneumologie de l'Hôpital Lyon Sud 1
Strasbourg
- Centre Paul Strauss 2
- Institut Public De Cancerologie Strauss Europe-Strauss Institute 1
- Institut de cancérologie Strasbourg Europe 1
- Institut de Cancérologie Strasbourg Europe (ICANS), Department of Oncology 1
- Institut public de cancérologie Strauss Europe 1
Bron
- Centre Hospitalier Lyon Sud / Hôpital Neurologique P. Wertheimer 1
- Hôpital Neurologique Pierre Wertheimer 1
- Hospices Civils de Lyon 1
- Service de NEURO-ONCOLOGIE du Groupement Hospitalier EST 1
- Hospices Civils de Lyon - Hopital Louis Pradel 1
- Hopital Neurologie Pierre Wetrheimer 1
Toulouse
- IUCT-O 1
- Hopital Larrey 1
- Hopital Rangueil 1
- Institut Universitaire du Cancer Toulouse - Oncopole 1
- Institut Universitaire du Cancer de Toulouse - Oncopole 1
- Institut Claudius Regaud 1
Villejuif
- Gustave Roussy 1
- Institut Gustave-Roussy 1
- Local Institution - 6108 1
- Institut Gustave Roussy 1
- Gustave Roussy Cancer Campus, Grand Paris 1
Bordeaux
- Centre Hospitalier Universitaire de Bordeaux - Groupe Hospitalier Pellegrin 1
- Institut Bergonié - Service d'Oncologie Médicale 1
- CHU de Bordeaux 1
- CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médicale 1
- Chu Saint Andre 1
Amiens
- CHU d'Amiens - CHU Amiens Picardie - Site Sud 1
- CHU Amiens Picardie 1
- CHU Amiens 1
- Chu Amiens Picardie 1
Lille
- CHRU de Lille 1
- Centre Oscar Lambret - cancerologie generale 1
- Hopital Roger Salengro 1
- CHU Lille 1
Nice
- CHU de Nice - Hôpital Pasteur 1
- Centre Hospitalier Universitaire de Nice, Department of Neurosurgery 1
- Centre Antoine Lacassagne - Service d'Hématologie Oncologie 1
- CHU de Nice 1
Dijon
- Centre Hospitalier Universitaire Dijon Bourgogne, Department of Neurosurgery 1
- Centre Georges François Leclerc 1
- Crlcc Georges Francois Leclerc 1
Rouen
- Centre Henri Becquerel 1
- CHU Rouen 1
- Crlcc Henri Becquerel 1
Clermont-Ferrand
- CLCC - Jean Perrin 1
- Centre Lutte Contre Le Cancer Jean Perrin 1
Montpellier
- Institut du Cancer de Montpellier 1
- Institut du Cancer de Montpellier - Val d'Aurelle 1
Nancy
- CHRU de Nancy 2
Vandœuvre-lès-Nancy
- ICL 1
- Cell Therapy Unit, Nancy Hospital 1
Suresnes
- Foch Hospital 1
- Hopital Foch 1
Brest
- CHRU de Brest - Hôpital Morvan 1
- Chu Brest Hopital Morvan 1
Caen
- Crlcc Francois Baclesse 1
- Arthur Leclerc 1
Saint-Herblain
- Institut de Cancerologie de l´Ouest (ICO) - Saint Herblain 1
Saint-Etienne
- Centre Hospitalier Universitaire de Saint-Étienne, Department of Neurosurgery 1
Tours
- Centre Hospitalier Régional et Universitaire de Tours (CHRU Tours), Department of Neurosurgery 1
Besançon
- CHU de Besançon 1
Angers
- Centre Hospitalier Universitaire D'Angers 1
Nantes
- Local Institution - 6112 1
Créteil
- Hôpital Henri Mondor - Université Paris-Est Créteil (UPEC) 1
Le Havre
- Groupe Hospitalier du Havre 1
Avignon
- Institut Sainte-Catherine 1
La Tronche
- Chu de Grenoble Alpes 1
Nîmes
- CHU de Nîmes - HOPITAL CAREMEAU 1
Orléans
- Ch Regional Orleans 1
Rennes
- CRLCC - Centre Eugène Marquis 1
Saint-Priest-en-Jarez
- Chu de Saint Etienne 1
Toulon
- Hia Sainte Anne 1
🇨🇳China90
Beijing
- Beijing Tiantan Hospital, Capital Medical University 8
- Beijing Tiantan Hospital 3
- District One Hospital 3
- Peking Union Medical College Hospital 2
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College 2
- Peking University Third Hospital 2
- Sanbo Brain Hospital, Capital Medical University 1
- Xuanwu Hospital, Capital Medical University 1
- Sanbo Brain Hospital Capital Medical University 1
- Beijing Cancer Hospital - Oncology Department 1
- Beijing chest hospital, Capital Medical University 1
- Beijing Cancer Hospital 1
- Beijing GoBroad Hospital 1
- Chinese PLA General Hospital 1
Hangzhou
- 2nd Affiliated Hospital, School of Medicine 2
- The Second Affiliated Hospital,School of Medicine,Zhejiang University 1
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China 1
- The Second Affiliated Hospital of Zhejiang University School of Medicine 1
- Sir Run Run Shaw Hospital, Zhejiang Univ. School of Medicine - Oncology Department 1
- the Second Affiliated Hospital, School of Medicine, Zhejiang University 1
- The Second Affiliated Hospital Zhejiang University School of Medicine 1
- Zhejiang Provincial People's Hospital 1
Shenzhen
- Peking University Shenzhen Hospital 3
- Shenzhen Second People's Hospital 2
- Shenzhen Geno-immuno Medical Institute 1
- Shenzhen Geno-immune Medical Institute 1
Zhengzhou
- Henan Provincial People's Hospital 3
- Zhengzhou Second Hospital 2
- Henan Academy of Innovations in Medical Science 2
Guangzhou
- Sun Yat-sen University Cancer Center 2
- Sun Yat-Sen University Cancer Center 2
- Nanfang Hospital, Southern Medical University 1
- the First Affiliated Hospital of Sun Yat-sen University 1
Shanghai
- Huashan Hospital Affiliated to Fudan University 1
- Huashan Hospital, Fudan University 1
- Huashan Hospital, Shanghai Medical College, Fudan University & Beijing TianTan Hospital,Capital Medical University 1
- Huashan Hospital 1
- Hushan Hospital, Fudan University 1
- Shanghai Tenth People's Hospital 1
Wuhan
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1
- Tongji Hosp. of Tongji Med Coll, Huazhong Uni of Sci & Tech. 1
- Zhongnan Hospital of Wuhan University 1
- Wuhan Union Hospital, China 1
Changsha
- Xiangya Hospital of Central South University 2
Chongqing
- Affiliated Tumor Hospital of Chongqing Medical University 1
- The Cancer Hospital Affiliated to Chongqing University 1
Jinan
- Affiliated Cancer Hospital of Shandong First Medical University 1
- Qilu Hospital of Shandong University 1
Tianjin
- Tianjin Medical University General Hospital 2
Zhuhai
- Yingpeng Peng 1
- The Fifth Affiliated Hospital of Sun Yat-sen University 1
Changchun
- Jilin Cancer Hospital 1
- The First Hospital of Jilin University 1
Shenyang
- Shengjing Hospital 2
Fuzhou
- The First Affiliated Hospital of Fujian Medical University 1
Chengdu
- West China Hospital of Sichuan University 1
Hefei
- The First Affiliated Hospital of USTC 1
Nanning
- Guangxi Medical University Cancer Hospital 1
Xi’an
- Tangdu Hospital of Air Force Medical University of the PLA 1
Nanjing
- Jiangsu Provincial People's Hospital - The First Affiliated Hospital of Nanjing Medical University 1
Mianyang
- Mianyang Central Hospital 1
Wenzhou
- The First Affiliated Hospital of Wenzhou Medical University 1
Qinhuangdao
- Qinhuangdao Runze Hospital 1
🇩🇪Germany70
Heidelberg
- Hopp Children's Cancer Center at NCT Heidelberg (KiTZ) 4
- Universitätsklinikum Heidelberg 3
- University Hospital Heidelberg 3
- Universitaetsklinikum Heidelberg - UniversitaetsKlinikum Heidelberg - Head Hospital 1
- Universitätsklinik Heidelberg 1
- University Hospital Heidelberg Department of Neurology Division of Neuro-Oncology 1
- Neurochirurgische Klinik, Universitätsklinikum Heidelberg 1
- University hospital Heidelberg 1
Munich
- Technical University Munich 5
- Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern 1
Essen
- Universitaetsklinikum - Essen 1
- University Hospital Essen Department of Neurology Clinical Neuro-Oncology 1
- University Hospital Essen 1
- University Hospital Essen, Department of Neurology, Division of Clinical Neuro-Oncology 1
Tübingen
- Universitätsklinikum Tübingen 2
- Universitaetsklinikum Tuebingen- Crona Kliniken 1
- University Hospital Tuebingen Department of Neurology and lnterdisciplinary Neuro-Oncology 1
Frankfurt
- Dr. Senckenbergisches Institut für Neuroonkologie 1
- University Hospital Frankfurt· Clinic for Neurology - Section Neurooncology 1
- Johann W. Goethe University Hospital, Department of Neurosurgery 1
- Johann W. Goethe University Hospital, Senckenberg Institute of Neurooncology 1
Mannheim
- Universitaetsklinikum Heidelberg - Neurologische Klinik 1
- Heidelberg University Faculty of Medicine in Mannheim Department of Neurology 1
- Neurochirurgische Klinik, Universitätsmedizin Mannheim 1
- Medical Center Mannheim 1
Münster
- Universitätsklinikum Münster 1
- University Hospital Münster, Klinik für Neurochirurgie 1
- University hospital Muenster 1
- Department of Neurosurgery 1
Bonn
- University Hospital Bonn 2
- University Hospital Bonn Department of Neurooncology 1
Cologne
- Universitaetsklinikum Koeln 1
- Uniklinik Koeln - Zentrum fuer Neurologie und Psychiatrie 1
- University Hospital Cologne Department of Neurology 1
Regensburg
- Universitaetskliniken Regensburg - Universitaetsklinikum Regensburg 1
- Universitätsklinikum Regensburg 1
- University Hospital Regensburg Neurology 1
Berlin
- Charité - University Medicine Berlin Department of Neurosurgery 1
- Charité Universitätsmedizin Berlin 1
- Charite 1
Bochum
- Univ. Knappschaft Krankenhaus Bochum 1
- University Hospital Knappschaftskrankenhaus Bochum 1
Erlangen
- Universitaetsklinikum Erlangen-Schwabachanlage 1
- University Hospital Erlangen Department of Neurosurgery 1
Leipzig
- Universitätsklinikum Leipzig-Klinik für Strahlentherapie und Radioonkologie 1
- University Hospital Leipzig 1
Stuttgart
- Clinical Center Stuttgart 1
- Klinikum Stuttgart 1
Erfurt
- Helios Klinikum Erfurt 1
Dresden
- University Hospital Carl Gustav Carus Dresden Department of Neurosurgery 1
Ulm
- University Hospital Ulm Department of Neurology /Center for NeuroOncology 1
Würzburg
- University Hospital Wuerzburg Department of Neurosurgery and Outpatient Center 1
Mainz
- Neurochirurgische Klinik, Universitätsmedizin Mainz 1
München
- Technical University of Munich 1
Lünen
- Clinical Center Lünen 1
Marburg
- Universitätsklinikum Gießen und Marburg 1
Hamburg
- University hospital Hamburg Eppendorf 1
🇦🇺Australia58
Melbourne
- Peter MacCallum Cancer Centre 2
- Royal Children's Hospital 2
- Austin Health 1
- The Alfred 1
- St Vincents Hospital Melbourne 1
- The Alfred Hospital 1
- Austin Hospital 1
Randwick
- Sydney Children's Hospital 4
- Local Institution - 6104 1
- Scientia Clinical Research 1
Perth
- Perth Children's Hospital 4
- Sir Charles Gairdner Hospital 1
South Brisbane
- Queensland Children's Hospital 4
- Children's Health Queensland Hospital and Health Service 1
Herston
- Royal Brisbane and Women's Hospital 3
St Leonards
- Northern Sydney Cancer Centre/Royal North Shore Hospital 1
- North Shore Private Hospital 1
- Royal North Shore Hospital 1
Heidelberg
- Austin Health 2
- Austin Hospital 1
Saint Leonards
- Royal North Shore Hospital 2
Nedlands
- Sir Charles Gairdner Hospital 1
- Perth Childrens Hospital 1
Waratah
- Calvary Mater Newcastle 1
- Calvary Mater Hospital Newcastle - Oncology 1
Bedford Park
- Flinders Medical Centre 1
- SOCRU - Southern Oncology Clinical Research Unit 1
Kogarah
- St George Private Hospital 1
- St. George Private hospital 1
Liverpool
- South Western Sydney Local Health District 1
- Ingham Institute of Applied Medical Research 1
Sydney
- St Vincent's Hospital 1
- Royal North Shore Hospital 1
Gold Coast
- Gold Coast University Hospital 1
Adelaide
- Royal Adelaide Hospital 1
Darlinghurst
- St Vincents Hospital Sydney (Kinghorn) 1
Parkville
- Peter MacCallum Cancer Centre 1
Miranda
- Southside Cancer Centre 1
Camperdown
- Chris O'Brien Lifehouse 1
Concord
- Concord Repatriation General Hospital (CRGH) (Concord Hospital) - Concord Cancer Centre 1
Epping
- Northern Hospital 1
Westmead
- Local Institution - 6103 1
Brisbane
- Princess Alexandra Hospital 1
🇳🇱Netherlands52
Rotterdam
- Erasmus MC 6
- Erasmus Medical Center 5
- Erasmus Medisch Centrum 1
- Erasmus MC, Department of Neurosurgery 1
The Hague
- Medical Center Haaglanden 2
- Haaglanden MC 2
- Haaglanden Medical Centre 2
- Haaglanden Medical Center 2
- Department of Neurosurgery, Haaglanden Medical Center, The Hague 1
Utrecht
- UMC Utrecht 3
- Princess Máxima Center 3
- Princess Máxima Center for Pediatric Oncology 1
- University Medical Center Utrecht 1
Amsterdam
- Amsterdam UMC 2
- The Netherlands Cancer Institute (NKI) 1
- Department of Neurosurgery, Amsterdam University Medical Center 1
- Nederlands Kanker Instituut 1
- Amsterdam UMC location VUmc 1
Groningen
- Universitair Medisch Centrum Groningen (UMCG) - UMC Groningen Comprehensive Cancer Center 1
- University Medical Center Groningen (UMCG) 1
- University Medical Center Groningen 1
- UMC Groningen 1
Tilburg
- ETZ Tilburg - ETZ - St. Elisabethziekenhuis 1
- Elisabeth-Tweesteden Ziekenhuis 1
- Elisabeth-TweeSteden Hospital 1
Leiden
- Leiden University Medical Centre 1
- Leiden UMC 1
Nijmegen
- Department of Neurosurgery, Radboud University Medical Center, Nijmegen 1
- Radboud UMC 1
Enschede
- Medisch Spectrum Twente 1
- Medical Spectrum Twente 1
Maastricht
- Maastricht UMC 2
Alkmaar
- Northwest Clinics 1
🇧🇪Belgium44
Leuven
- University Hospital Leuven 4
- UZ Leuven 3
- U.Z. Leuven - Campus Gasthuisberg 1
- UZ Leuven Gasthuisberg - Pneumology Department 1
- University Hospitals Leuven 1
Brussels
- Institut Jules Bordet 2
- Cliniques Universitaires Saint-Luc 1
- UZ Brussel 1
- Cliniques universitaires Saint-Luc 1
- HUB-Erasme Hospital 1
Ghent
- Universitair Ziekenhuis Gent 1
- Ghent University Hospital | Drug Research Unit Department 1
- AZ Sint-Lucas 1
- UZ Gent 1
- University Hospital Ghent 1
Liège
- Chu of Liège 1
- Centre Hospitalier Universitaire (CHU) de Liege - Domaine Universitaire du Sart Tilman - Medical Oncology 1
- CHU Liège 1
Aalst
- AZORG 1
- Olv Azorg 1
Gilly
- Grand Hopital de Charleroi - Site Les Viviers 1
- Grand Hôpital de Charleroi 1
Wilrijk
- Ziekenhuis aan de Stroom (ZAS) - ZAS Augustinus (previous GZA) 1
- ZAS Augustinus 1
Antwerp
- Antwerp University Hospital | Oncology Department 1
Baudour
- EpiCURA 1
Bruges
- AZ Sint Jan 1
Genk
- Ziekenhuis Oost-Limburg (ZOL) 1
Hasselt
- JESSA Ziekenhuis 1
Kortrijk
- AZ Groeninge 1
La Louvière
- Chu Helora 1
Mechelen
- AZ Sint Maarten 1
Montigny-le-Tilleul
- Hôpital André Vésale - HUmani 1
Mouscron
- CH Mouscron 1
Namur
- CHU UCL Namur - Sainte Elisabeth 1
Roeselare
- AZ Delta 1
Uccle
- Cliniques de l'Europe 1
Verviers
- CHR Verviers 1
🇪🇸Spain44
Madrid
- Hospital Universitario 12 de Octubre 3
- Hospital Universitario Fundacion Jimenez Diaz | Oncologia 1
- Clinica Universidad de Navarra (CUN) 1
- South Texas Accelerated Research Therapeutics (START) 1
- Hospital Infantil Universitario Nino Jesus 1
- Local Institution - 6106 1
- Clinica Universidad de Navarra 1
- HM Sanchinarro University Hospital 1
- Hospital Clínico San Carlos 1
Barcelona
- Hospital Clinic Barcelona 1
- Hospital del Mar 1
- Institut Catala d'Oncologia - L'Hospitalet 1
- Department of Neurosurgery, L'Hospitalet de Llobregat, Barcelona 1
- Hospital Hm Nou Delfos | Oncologia 1
- Hospital Universitari Vall D Hebron | Oncologia 1
- Hospital Universitario Vall d'Hebron 1
- Local Institution - 6105 1
- Hospital Universitari Vall d'Hebron 1
- Vall d'Hebron Institute of Oncology 1
- Hopsital Universitari Vall d'Hebron 1
Valencia
- Instituto Valenciano de Oncologia 1
- Hospital Clinico Universitario De Valencia | Oncologia 1
- Hospital Clinico Universitario de Valencia 1
- Hospital Universitario Y Politecnico La Fe 1
- Local Institution - 6107 1
- Hospital Clínic i Universitari de València 1
Pamplona
- Clinica Universidad De Navarra | Pamplona | Oncologia 1
- Clinica Universidad de Navarra (CUN) 1
- Clínica Universidad de navarra 1
Badalona
- Institut Catala d'Oncologia - ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (381) 1
- Hospital Germans Trias i Pujol 1
L'Hospitalet de Llobregat
- ICO L'Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) 1
Logroño
- Hospital San Pedro | Oncologia 1
Pozuelo de Alarcón
- NEXT - Hospital Universitario Quironsalud Madrid | Oncologia 1
Málaga
- Hospital Universitario Virgen De La Victoria | Oncologia 1
Boadilla del Monte
- HM Monteprincipe 1
Donostia / San Sebastian
- Hospital Universitario Donostia 1
Esplugues de Llobregat
- Hospital Sant Joan De Deu 1
Seville
- Hospital Universitario Virgen del Rocio 1
Alicante
- Hospital General Universitario Dr. Balmis 1
Murcia
- Hospital Clínico Universitario Virgen de la Arrixaca 1
Santa Cruz de Tenerife
- Hospital Universitario de Canarias 1
🇨🇭Switzerland38
Zurich
- University Hospital Zurich 5
- Universitätsspital Zürich 2
- UniversitaetsSpital Zurich - Neurology Clinic 1
- Universitaetsspital Zuerich 1
- UniversitatSpital USZ 1
- Universitaetsspital Zuerich - Klinik fuer Neurologie 1
- The University Children's Hospital in Zurich 1
Bern
- Inselspital Universitätsspital Bern 5
- Dep. of Neurosurgery, Bern University Hospital 2
- Bern Inselspital 1
- Department of Neurosurgery 1
- Inselspital University Hospital of Bern 1
Basel
- University Hospital Basel 3
- Universitätsspital Basel 3
Lausanne
- Centre Hospitalier Universitaire Vaudois Lausanne 1
- Centre Hospitalier Universitaire Vaudois 1
- Dep. of Neurosurgery, Centre hospitalier universitaire vaudois 1
Sankt Gallen
- Cantonal Hospital St Gallen 1
- Kantonsspital St. Gallen 1
Bellinzona
- Oncology Institute of Southern Switzerland (IOSI) - Ospedale San Giovanni 1
Aarau
- Kantonsspital Aarau 1
Fribourg
- HFR Fribourg - Hôpital cantonal 1
Lucerne
- Luzerner Kantonsspital 1
Lugano
- Ospedale Regionale di Lugano 1
🇮🇹Italy33
Milan
- IRCCS San Raffaele Scientific Institute 2
- Istituto Clinico Humanitas 1
- Istituto Nazionale Carlo Besta 1
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano 1
- IRCCS Ospedale San Raffaele 1
- Istituto Europeo di Oncologia 1
- Fondazione IRCCS Istituto Nazionale dei Tumori - S. C. Oncologia Medica 1 1
- Fondazione IRCCS - Istituto Nazionale dei Tumori 1
- IRCCS Galeazzi-Sant'Ambrogio 1
Rome
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS - UOC Fase I 1
- I.F.O. Istituti Fisioterapici Ospitalieri - Sperimentazioni cliniche Fase 1 e Medicina di precisione 1
- Local Institution - 4302 1
- Fondazione Policlinico Universitario A. Gemelli IRCCS 1
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1
Padova
- IRCCS - Istituto Oncologico Veneto 1
- Istituto Oncologico Veneto-I.R.C.C.S. - Ospedale Busonera 1
- Local Institution - 6113 1
Rozzano
- Humanitas Mirasole S.p.A. - Oncologia Medica ed Ematologia 1
- Istituto clinico humanitas 1
- IRCCS Istituto Clinico Humanitas 1
Bologna
- IRCCS-Ospedale Bellaria-Bologna 1
- IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant'Orsola 1
Roma
- Azienda ospedaliero Univ Policlinico Umberto I 1
- Fondazione Policlinico Universitario A. Gemelli IRCCS 1
Torino
- Local Institution - 6114 1
- AOU Città della Salute e della Scienza 1
Legnago
- ULSS 9 Scaligera Veneto - Azienda Unita Locale Socio-Sanitaria N. 9-Mater Salutis Hospital 1
Livorno
- Spidali Riuniti Di Livorno 1
Florence
- Meyer Children's Hospital IRCCS 1
Meldola
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori 1
Aviano
- Centro di Riferimento Oncologico di Aviano - Oncologia Medica e dei Tumori Immuno-Correlati 1
Genova
- IRCCS Azienda Ospedaliera Metropolitana 1
🇬🇧United Kingdom31
London
- Great Ormond Street Hospital 3
- University College London Hospital 2
- The Royal Marsden NHS Foundation Trust 1
- Great Ormond Street Hospital For Children NHS Foundation Trust 1
- King's College NHS Foundation Trust 1
- Dysplasia Diagnostics Limited 1
Sutton
- Royal Marden NHS Foundation Trust 1
- The Royal Marsden (Surrey) | Oak Foundation Drug Development Unit 1
- The Royal Marsden Hospital - Drug Development Unit 1
- The Royal Marsden Hospital - Neuro-Oncology Unit 1
- Royal Marsden Hospital-Sutton - Dept of Oncology (Surrey) 1
Manchester
- The Christie NHS Foundation Trust 2
- The Christie Hospital | Experimental Cancer Medicine Team 1
Birmingham
- University Hospitals Birmingham NHS Foundation Trust 1
- Local Institution - 4403 1
Cambridge
- Cambridge University Hospitals 1
- Babraham Research Institute 1
Liverpool
- Alder Hey Children's NHS Foundation Trust 1
- Research Site 1
Surrey Quays
- Royal Marsden Hospital - Surrey 1
Edinburgh
- Royal Infirmary of Edinburgh 1
Cardiff
- University Hospital of Wales 1
Glasgow
- Royal Hosp. for Children 1
Guildford
- Research Site 1
Sheffield
- Sheffield Teaching Hospitals NHS Foundation Trust 1
Swansea
- Swansea Bay University Health Board 1
Aberdeen
- University of Aberdeen 1
🇨🇦Canada30
Toronto
- The Hospital for Sick Children (SickKids) 4
- Sunnybrook Health Sciences Centre 3
- Princess Margaret Cancer Centre 2
- Princess Margaret Hospital 1
- Sunnybrook Health Sciences Centre - Odette Cancer Centre 1
Montreal
- Montreal Children's Hospital 4
- Montreal Neurological Institute and Hospital, McGill University 1
- McGill University Health Center - Research Institute 1
- St Justine Hospital 1
Sherbrooke
- CHUS 2
- Université de Sherbrooke 1
Edmonton
- Cross Cancer Institute 2
- Stollery Children'S Hospital 1
Ottawa
- The Ottawa Hospital Cancer Centre 2
- Children'S Hospital Of Eastern Ontario 1
Winnipeg
- Cancer Care Manitoba 1
Calgary
- University Of Calgary 1
London
- London Health Sciences Centre 1
🇰🇷South Korea18
Seoul
- Asan Medical Center 3
- Seoul National University Hospital 2
- Severance hospital 1
- Severance Hospital, Yonsei University Health System 1
- Samsung Medical Center 1
- Local Institution - 6303 1
- Local Institution - 6304 1
- Gangnam Severance Hospital 1
Incheon
- The Catholic University of Korea, Incheon St. Mary's Hospital 1
- Gachon University Gil Medical Center 1
Seongnam-si
- Seoul National University Bundang Hospital 1
- CHA Bundang Medical Center 1
Seongnam
- Bundang CHA Medical Center 1
Busan
- Dong-A University Hospital 1
Daejeon
- Chungnam National University Hospital 1
🇹🇼Taiwan18
Taipei
- National Taiwan University Hospital 2
- Koo Foundation Sun Yat-Sen Cancer Center 1
- Local Institution - 6202 1
- Taipei Medical University Hospital 1
Taichung
- Taichung Veterans General Hospital 3
- China Medical University Hospital 1
Taoyuan
- Linkou Chang Gung Memorial Hospital 1
- Chang-Gung Memorial Hospital at Lin-Ko 1
- Chang Gung Memorial Hospital, Linkou 1
Kaohsiung City
- Kaohsiung Medical University Chung-Ho Memorial Hospital 2
- Chang Gung Memorial Hospital, Kaohsiung 1
Taoyuan City
- Linkou Chang-Gung Memorial Hospital 2
Hualien City
- Hualien Tzu Chi Hospital 1
🇸🇪Sweden17
Lund
- Skåne University Hospital 2
- Department of Neurosurgery, Skane University Hospital 1
- Department of Neurosurgery 1
Gothenburg
- Sahlgrenska University Hospital 1
- University of Gothenburg, Department of Clinical Neuroscience 1
- Sahlgrenska Universitetssjukhuset - Sahlgrenska Sjukhuset - Klinisk prövningsenhet Fas I/FIH 1
Stockholm
- Karolinska Institutet 1
- Karolinska Universitetssjukhuset - Solna - Fas I-enheten Solna CKC 1
Umeå
- Norrlands Universitetssjukhus, Umea, Sweden 1
- University Hospital of Umeå, Department of Diagnostics and Intervention 1
Gävle
- Gävle Hospital 1
Jönköping
- Ryhov County Hospital 1
Kalmar
- Kalmar Country Hospital 1
Örebro
- Örebro University Hospital 1
Sundsvall
- Sundsvall Hospital 1
Uppsala
- Uppsala University Hospital 1
🇦🇹Austria13
Linz
- Johannes Kepler University 1
- Kepler University Hospital 1
- Kepler University Hospital - Neuromed campus 1
- Johannes Kepler University Linz University, Clinic for Neurosurgery 1
Vienna
- AKH Vienna, Department for Internal Medicine I, Oncology 2
- Universitaetsklinikum Wien - AKH unikliniken 1
- Medical University of Vienna, Department of Neurosurgery 1
Innsbruck
- Medizinische Universität Innsbruck 1
- A.O Landeskrankenhaus - Innsbruck Universitaetsklinik 1
- Universitätsklinikum Innsbruck 1
Graz
- University Hospital Graz 1
Sankt Pölten
- University Hospital St. Pölten 1
🇩🇰Denmark10
Aarhus
- Aarhus University Hospital 1
- Aarhus University Hospitals - Region Midtjylland - Aarhus University Hospital-Skejby 1
- Aarhus University Hospital, Department of Neurosurgery 1
- Aarhus University Hospital, Dept. of Oncology 1
- Danish Centre for Particle Therapy 1
Copenhagen
- Rigshospitalet Copenhagen University Hospital | Oncology Department 1
- Rigshospitalet - Glostrup 1
- Rigshospitalet 1
- Copenhagen University Hospital, Rigshospitalet 1
Odense
- Odense University Hospital | Svendborg Sygehus - Oncology Department 1
🇳🇴Norway9
Oslo
- Oslo University Hospital 2
- Oslo University Hospital - Radiumhospitalet 1
Bergen
- Haukeland University Hospital 2
Trondheim
- St Olavs Hospital 1
- St Olavs University Hospital - St. Olavs Hospital, Trondheim University Hospital 1
Kristiansand
- Sorlandet Sykehus 1
Stavanger
- Stavanger University Hospital 1
🇵🇱Poland9
Warsaw
- Department of Neurosurgery, Medical University of Warsaw, Banacha 1a 2
- Department of Neurosurgery, National Instiute of Oncology, W.K. Roentgena 5 2
- Department of Neurosurgery of Medical University of Warsaw 1
- Department of Neurosurgery of Medical Univeristy of Warsaw 1
Bydgoszcz
- Department of Neurooncology and Radiosurgery, Franciszek Lukaszczyk Oncology Center 1
Lodz
- Copernicus Memorial Hospital in Łódź, Poland 1
Poznan
- University Hospital 1
🇸🇬Singapore7
Singapore
- National Neuroscience Institute 1
- National Cancer Centre Singapore 1
- National University Hospital Medical Centre 1
- National Cancer Center Singapore - Oncology Department 1
- Icon Cancer Centre 1
- National University Hospital 1
- KK Women's and Children's Hospital 1
🇯🇵Japan7
Nagoya
- Nagoya University Hospital 1
Kashiwa
- National Cancer Center Hospital East 1
Sakai
- Kindai University Hospital 1
Sunto
- Shizuoka Cancer Center 1
Chuo-ku
- National Cancer Center Hospital 1
Koto-ku
- The Cancer Institute Hospital of JFCR 1
Chūōku
- National Cancer Center Hospital 1
🇳🇿New Zealand4
Auckland
- Starship Children's Hospital 4
🇨🇿Czechia3
Brno
- Masaryk Memorial Cancer Institute 1
- Masarykova Univerzita - Masarykuv Onkologicky Ustav (MOU) - Klinika Komplexni Onkologicke Pece (KKOP) 1
Olomouc
- Fakultní nemocnice Olomouc - Onkologická klinika 1
🇬🇷Greece3
Larissa
- Department of Neurosurgery, Hospital of Larissa & General Hospital of Larissa 1
- University Hospital of Larissa 1
Pátrai
- Olympion Medical Center 1
🇮🇳India2
Mumbai
- Tata Memorial Hospital 2
🇭🇺Hungary2
Budapest
- Orszagos Koranyi Pulmonologiai Intezet 1
Tatabánya
- Komarom-Esztergom Varmegyei Szent Borbala Korhaz 1
🇷🇺Russia2
Saint Petersburg
- Private Medical Institution Euromedservice 1
Moscow
- Joint-Stock Company European Medical Center 1
🇵🇹Portugal2
Lisbon
- Department of Neurosurgery, Centro Hospitalar Universitário Lisboa Norte - Hospital de Santa Maria 1
Porto
- Unidade Local de Saúde de São João 1
🇵🇷Puerto Rico2
Bayamón
- Universidad Central del Caribe 1
San Juan
- Massive Bio SYNERGY-AI site 1
🇮🇪Ireland2
Dublin
- Beaumont RCSI Cancer Centre 1
Beaumont
- Beaumont RCSI Cancer Centre 1
🇮🇷Iran1
Tehran
- Rasoul Akram hospital 1
🇮🇱Israel1
Ramat Gan
- Sheba medical center 1
🇺🇿Uzbekistan1
Tashkent
- Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology Uzbekistan 1
🇦🇷Argentina1
Rosario
- Various Cancer Centres 1
🇳🇬Nigeria1
Lagos
- NSIA- Lagos University Teaching Hospital Cancer Centre 1
🇷🇪Reunion1
Saint-Pierre
- Mélanie BEGORRE 1
Source: ClinicalTrials.gov study locations, fetched 2026-11-10. Counts are trials at that site.